Concourse Financial Group Securities’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,721
Closed -$674K 1125
2024
Q4
$674K Sell
6,721
-319
-5% -$32K 0.04% 411
2024
Q3
$590K Sell
7,040
-677
-9% -$56.7K 0.04% 422
2024
Q2
$594K Sell
7,717
-124
-2% -$9.55K 0.04% 403
2024
Q1
$537K Buy
7,841
+570
+8% +$39K 0.03% 428
2023
Q4
$420K Sell
7,271
-102
-1% -$5.9K 0.03% 476
2023
Q3
$389K Sell
7,373
-423
-5% -$22.3K 0.03% 459
2023
Q2
$422K Buy
7,796
+2,857
+58% +$155K 0.03% 465
2023
Q1
$247K Buy
4,939
+1,916
+63% +$95.9K 0.02% 588
2022
Q4
$140K Sell
3,023
-261
-8% -$12.1K 0.01% 726
2022
Q3
$127K Sell
3,284
-304
-8% -$11.8K 0.01% 653
2022
Q2
$134K Sell
3,588
-514
-13% -$19.2K 0.01% 713
2022
Q1
$182K Sell
4,102
-747
-15% -$33.1K 0.01% 657
2021
Q4
$206K Buy
4,849
+113
+2% +$4.8K 0.01% 718
2021
Q3
$205K Buy
4,736
+1,197
+34% +$51.8K 0.01% 710
2021
Q2
$151K Buy
3,539
+35
+1% +$1.49K 0.01% 813
2021
Q1
$135K Sell
3,504
-1,662
-32% -$64K 0.01% 811
2020
Q4
$186K Sell
5,166
-9,919
-66% -$357K 0.01% 649
2020
Q3
$576K Buy
15,085
+1,341
+10% +$51.2K 0.05% 307
2020
Q2
$483K Buy
13,744
+1,646
+14% +$57.8K 0.05% 313
2020
Q1
$395K Sell
12,098
-1,535
-11% -$50.1K 0.04% 293
2019
Q4
$616K Buy
13,633
+8,785
+181% +$397K 0.06% 241
2019
Q3
$197K Buy
4,848
+528
+12% +$21.5K 0.05% 296
2019
Q2
$186K Buy
4,320
+999
+30% +$43K 0.02% 488
2019
Q1
$127K Sell
3,321
-2,312
-41% -$88.4K 0.01% 605
2018
Q4
$199K Buy
5,633
+4,792
+570% +$169K 0.02% 430
2018
Q3
$32K Buy
+841
New +$32K 0.01% 691